TWEAK/Fn14 signalling in Breast Cancer [cell line K27 ChIP]
This study explores the transcriptiomic and epigenetic roles of TWEAK/Fn14 signalling in Breast Cancer Overall design: Chromatin immunoprecipitation-sequencing (ChIP-seq) for the histone modification H3K27ac in untreated and TWEAK treated breast cancer cell lines: MDA-MB-231, Hs578T, MCF7 and CAMA1.